American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

Modified-Release Formulation of Decitabine and Tetrahydrouridine Combination Not Only Increases Exposure to Decitabine but Reduces Exposure to Unfavorable Decitabine Metabolites in Healthy Volunteers

Authors :

Helene Hausner¹, Hanne Kjær Offenberg¹, Marie Aavang Geist¹, Samar Al-Behaisi², Hans Helleberg¹

Affiliations

View Details Hide Details

PDF default button label

Keywords

Sickle Cell Disease

Congress poster

NDec

Are you a healthcare professional?